Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus [published erratum appears in J Exp Med 1987 Nov 1;166(5):following 1608]

doi:10.1084/jem.166.3.668

This Article

	Full Text (PDF, 632K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Volkmer, H.
	Articles by Koszinowski, U. H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Volkmer, H.
	Articles by Koszinowski, U. H.


Social Bookmarking

	What's this?

ARTICLES

Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus [published erratum appears in J Exp Med 1987 Nov 1;166(5):following 1608]

H Volkmer, C Bertholet, S Jonjic, R Wittek and UH Koszinowski

The murine immediate-early (IE) protein pp89 is a nonstructural virus- encoded phosphoprotein residing in the nucleus of infected cells, where it acts as transcriptional activator. Frequency analysis has shown that in BALB/c mice the majority of virus-specific CTL recognize IE antigens. The present study was performed to assess whether pp89 causes membrane antigen expression detected by IE-specific CTL. Site-directed mutagenesis has been used to delete the introns from gene ieI, encoding pp89, for subsequent integration of the continuous coding sequence into the vaccinia virus genome. After infection with the vaccinia recombinant, the authentic pp89 was expressed in cells that became susceptible to lysis by an IE-specific CTL clone. Priming of mice with the vaccinia recombinant sensitized polyclonal CTL that recognized MCMV- infected cells and transfected cells expressing pp89. Thus, a herpesviral IE polypeptide with essential function in viral transcriptional regulation can also serve as a dominant antigen for the specific CTL response of the host.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Krauss, S., Kaps, J., Czech, N., Paulus, C., Nevels, M. (2009). Physical Requirements and Functional Consequences of Complex Formation between the Cytomegalovirus IE1 Protein and Human STAT2. J. Virol. 83: 12854-12870 [Abstract] [Full Text]
Andrews, D. M., Andoniou, C. E., Fleming, P., Smyth, M. J., Degli-Esposti, M. A. (2008). The Early Kinetics of Cytomegalovirus-Specific CD8+ T-Cell Responses Are Not Affected by Antigen Load or the Absence of Perforin or Gamma Interferon. J. Virol. 82: 4931-4937 [Abstract] [Full Text]
Crompton, L., Khan, N., Khanna, R., Nayak, L., Moss, P. A. H. (2008). CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals. Blood 111: 2053-2061 [Abstract] [Full Text]
Halenius, A., Momburg, F., Reinhard, H., Bauer, D., Lobigs, M., Hengel, H. (2006). Physical and Functional Interactions of the Cytomegalovirus US6 Glycoprotein with the Transporter Associated with Antigen Processing. J. Biol. Chem. 281: 5383-5390 [Abstract] [Full Text]
Hasan, M., Krmpotic, A., Ruzsics, Z., Bubic, I., Lenac, T., Halenius, A., Loewendorf, A., Messerle, M., Hengel, H., Jonjic, S., Koszinowski, U. H. (2005). Selective Down-Regulation of the NKG2D Ligand H60 by Mouse Cytomegalovirus m155 Glycoprotein. J. Virol. 79: 2920-2930 [Abstract] [Full Text]
Krmpotic, A., Hasan, M., Loewendorf, A., Saulig, T., Halenius, A., Lenac, T., Polic, B., Bubic, I., Kriegeskorte, A., Pernjak-Pugel, E., Messerle, M., Hengel, H., Busch, D. H., Koszinowski, U. H., Jonjic, S. (2005). NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. JEM 201: 211-220 [Abstract] [Full Text]
Morello, C. S., Ye, M., Spector, D. H. (2002). Development of a Vaccine against Murine Cytomegalovirus (MCMV), Consisting of Plasmid DNA and Formalin-Inactivated MCMV, That Provides Long-Term, Complete Protection against Viral Replication. J. Virol. 76: 4822-4835 [Abstract] [Full Text]
Schwarz, K., de Giuli, R., Schmidtke, G., Kostka, S., van den Broek, M., Kim, K. B., Crews, C. M., Kraft, R., Groettrup, M. (2000). The Selective Proteasome Inhibitors Lactacystin and Epoxomicin Can Be Used to Either Up- or Down-Regulate Antigen Presentation at Nontoxic Doses. J. Immunol. 164: 6147-6157 [Abstract] [Full Text]
Morello, C. S., Cranmer, L. D., Spector, D. H. (2000). Suppression of Murine Cytomegalovirus (MCMV) Replication with a DNA Vaccine Encoding MCMV M84 (a Homolog of Human Cytomegalovirus pp65). J. Virol. 74: 3696-3708 [Abstract] [Full Text]
MacDonald, M. R., Li, X.-Y., Stenberg, R. M., Campbell, A. E., Virgin, H. W. IV (1998). Mucosal and Parenteral Vaccination against Acute and Latent Murine Cytomegalovirus (MCMV) Infection by Using an Attenuated MCMV Mutant. J. Virol. 72: 442-451 [Abstract] [Full Text]